Laserfiche WebLink
Appendix E.1:Data Usability Summary <br /> A summary of qualified data is provided in Table E-2. Data validation reason codes for all <br /> qualified data are also presented and defined on Table E-2. <br /> Precision and Accuracy <br /> The precision and accuracy of field and laboratory QC samples were evaluated. The calculated <br /> relative percent differences (RPDs) for MS/MSD and field duplicate pairs provided information <br /> on the precision of sampling and analytical procedures. The RPDs for laboratory control <br /> sample/laboratory control sample duplicates (LCS/LCSDs)provided information on the <br /> precision of the analytical procedures. Evaluation of the percent recoveries (%Rs) of MS/MSDs, <br /> LCS/LCSDs, and surrogates provided information on accuracy. <br /> LCS/LCSDs <br /> An LCS was analyzed with each analytical batch of samples. An LCSD was analyzed with some <br /> batches of samples. All LCS/LCSD %Rs were within the laboratory control limits with two <br /> exceptions: <br /> • The %R for anthracene was 67 percent,below the control limit of 70 percent, in the LCS <br /> associated with samples SB-18-S-5-080811, SB-19-S-5-080811, SB-18-S-59.5-080811, <br /> SB-18-S-40.5-080811, SB-19-S-37-080811, SB-20-S-5-080812, SB-20-27.5-080812, <br /> SB-20-S-40-080812, SB-21-S-5-080812, SB-22-S-5-0808012, and SB-23-S-5-080812. <br /> • The %R for benzo(a)anthracene was 79 percent,below the control limit of 80 percent, in <br /> the LCS associated with sample SB-22-W-080813, field duplicate SB-22-WD-080813, <br /> and equipment rinsate QA—Screen-R-080814. <br /> The recoveries for anthracene and benzo(a)anthracene were outside the QC windows, but within <br /> the marginal exceedence allowance+/-4 standard deviations as defined in the NELAC <br /> standards, and were accepted by the laboratory based on this allowance. No flags were applied <br /> for the marginal exceedences because the deviations are not expected to bias the sample results. <br /> Continuing Calibration Verification (CCV)Standards <br /> Percent differences (%Ds) for CCVs were not reviewed as part of the data evaluation process for <br /> data collected at the US Can—Welty Road site. However, the laboratory noted in the analytical <br /> reports that the CCVs analyzed before several samples for TPHd analysis were below the <br /> acceptance range. The samples were re-analyzed after a CCV within the acceptance criteria; <br /> however, the ending CCV for the second analyses was above the acceptance limit. The TPHd <br /> results were qualified E from samples SB-26-W-82-080815, SB-24B-W-39-080814, and SB-25- <br /> W-35-080818 for a potential bias. TPHd were not detected in samples QA-Tubing-R-080815, <br /> QA-Rinsate-Blank-R080815, and SB-27-W-36-080818. The results were not qualified because <br /> the second analysis confirmed the original analysis of these samples, and the results are not <br /> expected to be biased due to the CCV exceedence. <br /> Surrogates <br /> Surrogate recoveries were evaluated for all BTEX, PAH, and TPH methods. Three surrogates <br /> were used in the analysis of PAHs: nitrobenzene-d5, 2-fluorbiphenyl, and terphenyl-d14. PAH <br /> surrogate nitrobenzene-d5 is not associated with the target PAHs, and was not used to qualify <br /> sample results. The laboratory reported two surrogates for the TPHc analysis: chlorobenzene <br /> and orthoterphenyl. The recoveries for chlorobenzene were not evaluated because the compound <br /> does not elute within the target carbon range. Surrogate recoveries in all analyses were not <br /> E.1-3 <br /> �.:::: <br /> MMMFJ'11%�& <br /> From Science to Selatierrs <br />